Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Perfect

Showing results (301-310 of 328) with videos related to

Pageof 33
Sort By:
Frontiers in Cellular and Infection Microbiology|July 19, 2021
Comparison of <i>Cryptococcus gattii</i>/<i>neoformans</i> Species Complex to Related Genera (<i>Papiliotrema</i> and <i>Naganishia</i>) Reveal Variances in Virulence Associated Factors and Antifungal SusceptibilityLana Sarita de Souza Oliveira, Luciana Magalhães Pinto, Mariana Araújo Paulo de Medeiros, et al.
Mbio|November 10, 2022
Genomic Variation across a Clinical Cryptococcus Population Linked to Disease OutcomePoppy Sephton-Clark, Jennifer L Tenor, Dena L Toffaletti, et al.
Trials|June 18, 2015
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trialMooketsi Molefi, Awilly A Chofle, Síle F Molloy, et al.
Science Translational Medicine|January 22, 2016
CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survivalMuthulekha Swamydas, Ji-Liang Gao, Timothy J Break, et al.
Mbio|August 27, 2024
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitisKatharine E Stott, Jason T Mohabir, Katharine Bowers, et al.
Medical Mycology|April 10, 2014
Role of autophagy genetic variants for the risk of Candida infectionsDiana C Rosentul, Theo S Plantinga, Marius Farcas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2011
Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort studyMelissa D Johnson, Theo S Plantinga, Esther van de Vosse, et al.
Nature Communications|September 9, 2014
Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemiaVinod Kumar, Shih-Chin Cheng, Melissa D Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2006
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trialThomas J Walsh, Issam Raad, Thomas F Patterson, et al.
The Journal of Infectious Diseases|February 4, 2012
Toll-like receptor 1 polymorphisms increase susceptibility to candidemiaTheo S Plantinga, Melissa D Johnson, William K Scott, et al.
Pageof 33

Showing results (301-310 of 328) with videos related to

Sort By:
Pageof 33
Frontiers in Cellular and Infection Microbiology|July 19, 2021
Comparison of <i>Cryptococcus gattii</i>/<i>neoformans</i> Species Complex to Related Genera (<i>Papiliotrema</i> and <i>Naganishia</i>) Reveal Variances in Virulence Associated Factors and Antifungal SusceptibilityLana Sarita de Souza Oliveira, Luciana Magalhães Pinto, Mariana Araújo Paulo de Medeiros, et al.
Mbio|November 10, 2022
Genomic Variation across a Clinical Cryptococcus Population Linked to Disease OutcomePoppy Sephton-Clark, Jennifer L Tenor, Dena L Toffaletti, et al.
Trials|June 18, 2015
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trialMooketsi Molefi, Awilly A Chofle, Síle F Molloy, et al.
Science Translational Medicine|January 22, 2016
CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survivalMuthulekha Swamydas, Ji-Liang Gao, Timothy J Break, et al.
Mbio|August 27, 2024
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitisKatharine E Stott, Jason T Mohabir, Katharine Bowers, et al.
Medical Mycology|April 10, 2014
Role of autophagy genetic variants for the risk of Candida infectionsDiana C Rosentul, Theo S Plantinga, Marius Farcas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2011
Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort studyMelissa D Johnson, Theo S Plantinga, Esther van de Vosse, et al.
Nature Communications|September 9, 2014
Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemiaVinod Kumar, Shih-Chin Cheng, Melissa D Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2006
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trialThomas J Walsh, Issam Raad, Thomas F Patterson, et al.
The Journal of Infectious Diseases|February 4, 2012
Toll-like receptor 1 polymorphisms increase susceptibility to candidemiaTheo S Plantinga, Melissa D Johnson, William K Scott, et al.
Pageof 33